hepat
b
viru
hbv
infect
liver
primari
target
result
major
case
acut
hepat
nevertheless
million
peopl
chronic
infect
hbv
worldwid
despit
high
incid
infect
cellular
receptor
hbv
entri
still
unknown
sever
put
bind
factor
describ
hbv
surfac
antigen
hbsag
human
serum
albumin
asialoglycoprotein
receptor
heparin
mannos
bind
lectin
exact
role
hbv
attach
uptak
remain
unclear
hepat
b
viru
dna
viru
consist
core
particl
envelop
small
middl
larg
l
surfac
antigen
gener
refer
hbsag
three
surfac
antigen
contain
common
domain
l
protein
contain
domain
l
exclus
contain
domain
liver
peripher
blood
hbv
infect
individu
reach
level
infecti
particl
per
ml
addit
hbsag
secret
infect
hepatocyt
spheric
subvir
particl
filament
accumul
peripher
blood
main
compon
hbv
virion
hbsag
subvir
particl
l
highli
enrich
hbv
virion
modif
surfac
antigen
crucial
hbv
life
cycl
myristoyl
domain
essenti
infect
inhibit
domain
prevent
secret
viral
particl
recent
domain
report
well
although
seem
dispens
hbv
morphogenesi
might
involv
viral
attach
first
step
clearanc
viral
infect
involv
recognit
viru
innat
immun
system
mediat
host
pattern
recognit
receptor
prr
receptor
lectin
lectin
recogn
highli
conserv
carbohydr
structur
lead
intern
antigen
process
present
cell
prototyp
member
lectin
famili
dendrit
lectin
recogn
broad
rang
glycosyl
pathogen
mannos
fucos
contain
carbohydr
includ
hepat
c
viru
hcv
ebola
viru
dengu
viru
measl
viru
human
herpesviru
sar
coronaviru
cytomegaloviru
mycobacterium
tubercolosi
helicobact
pylori
streptococcu
pneumonia
neisseria
meningitidi
outcom
interact
mani
pathogen
evolv
subvert
immun
surveil
function
benefit
intern
rout
nonlysosom
compart
protect
transmiss
target
cell
pathogen
also
modul
adapt
immun
respons
interact
eg
tuberculosi
exploit
escap
immun
surveil
inhibit
immunostimulatori
function
dendrit
cell
well
establish
envelop
glycoprotein
hcv
interact
homologu
express
sinusoid
endotheli
cell
liver
lymph
node
hcv
particl
interact
lead
effici
captur
intern
transport
nonlysosom
compart
within
immatur
dendrit
cell
therebi
protect
viru
degrad
similarli
hcv
particl
interact
express
liver
sinusoid
endotheli
cell
lsec
situ
target
nonlysosom
earli
endosom
transfect
raji
cell
also
thought
play
import
role
hcv
viral
dissemin
transfer
hcv
circul
hepatocyt
main
hcv
target
cell
sever
report
shown
presenc
hbv
within
dendrit
cell
suggest
involv
dendrit
receptor
hbsag
preferenti
internalis
human
lsec
mix
cultur
human
hepatocyt
k
esser
u
protzer
unpublish
data
also
report
duck
hbv
impli
potenti
interact
hbv
hbv
glycosyl
pattern
togeth
cellular
local
prompt
us
investig
possibl
role
bind
hbv
follow
antibodi
use
specif
antibodi
mous
conjug
fluorescein
isothiocyan
fitc
clone
bd
bioscienc
san
jose
ca
usa
mous
innogenet
ghent
belgium
sheep
mous
biotinyl
human
kind
gift
r
heijtink
erasmu
mc
rotterdam
netherland
rabbit
acri
antibodi
gmbh
hiddenhausen
germani
goat
immunoglobulin
jackson
immunoresearch
west
grove
pa
usa
rabbit
dako
glostrup
denmark
goat
caltag
carlsbad
ca
usa
streptavidin
dako
recombin
hbv
surfac
antigen
hbsag
contain
domain
purifi
transfect
chines
hamster
ovari
cho
cell
kindli
provid
van
roosmalen
boxtel
netherland
yeast
hcv
glycoprotein
reconstitut
particl
vlp
kindli
provid
depraeter
innogenet
cell
grown
confluenc
william
e
medium
gibco
paisley
uk
supplement
foetal
calf
serum
fc
hyclon
logan
ut
usa
secret
hbv
subvir
particl
concentr
medium
describ
final
concentr
hbv
particlesml
enrich
hbv
subvir
particl
cultur
supernat
load
pb
equilibr
ml
bed
volum
hi
traptm
heparin
hp
column
ge
healthcar
ab
uppsala
sweden
fifteen
column
volum
pb
wash
hbv
particl
elut
ml
elut
buffer
mm
nacl
mm
ph
collect
elut
fraction
ml
flow
rate
mlmin
elut
fraction
dialyz
pb
neg
control
procedur
follow
supernat
untransfect
cell
elut
fraction
assess
presenc
hbv
particl
l
immunosorb
assay
elisa
captur
hbv
specif
antibodi
respect
bound
hbv
detect
biotinyl
human
quantif
hbv
particl
done
taqman
hbv
test
roch
diagnost
gmbh
mannheim
germani
viral
dna
isol
use
high
pure
system
viral
nucleic
acid
kit
roch
diagnost
penzberg
germani
gener
highli
mannosyl
hbv
cell
treat
inhibitor
kifunensin
day
calbiochem
darmstadt
germani
untreat
cell
kifunsin
treat
cell
serv
neg
control
final
concentr
highli
mannosyl
nativ
hbv
hbv
particlesml
respect
stabl
raji
transfect
express
gener
previous
describ
dendrit
cell
modc
cultur
monocyt
presenc
uml
respect
brussel
belgium
day
phenotyp
cultur
modc
confirm
flow
cytometr
analysi
express
level
transfect
raji
cell
modc
determin
flow
cytometri
specif
antibodi
heparin
purifi
glycan
modifi
nativ
hbv
captur
elisa
plate
maxisorb
nunc
roskild
denmark
mous
recombin
hbsag
hcv
vlp
mannan
st
loui
mo
usa
coat
directli
onto
plate
h
block
bovin
serum
albumin
h
follow
biotinyl
plant
lectin
ad
h
room
temperatur
concentr
con
concavalin
recogn
gna
galanthu
nivali
agglutinin
wga
wheat
germ
agglutinin
pna
arachi
hypogaea
agglutinin
rcaii
ricinu
communi
agglutinin
lta
lotu
tetragonolobu
agglutinin
fucos
sigma
aldrich
lectin
bind
detect
use
streptavidin
absorb
measur
nm
bind
assay
perform
previous
describ
short
recombin
hbsag
hbv
control
captur
maxisorb
elisa
plate
nunc
mous
hcv
vlp
coat
directli
plate
block
bovin
serum
albumin
min
solubl
ad
bound
detect
incub
immunoglobulin
antibodi
specif
bind
determin
block
either
mannan
egta
mm
assess
coat
effici
hbsag
hbv
detect
biotinyl
human
hcv
vlp
detect
mous
hbv
concentr
centrifug
purifi
heparin
column
gave
similar
result
bind
assay
raji
transfect
lyse
h
lysi
buffer
mm
nacl
mm
mm
pb
supplement
ethylenediamin
tetraacet
acid
edta
proteas
inhibitor
roch
diagnost
hbsag
hbv
medium
control
captur
elisa
plate
mous
antibodi
hcv
vlp
coat
directli
plate
block
bovin
serum
albumin
min
raji
lysat
ad
h
rt
bound
detect
specif
antibodi
clone
follow
rabbit
antibodi
specif
bind
determin
presenc
mannan
assess
coat
effici
hbsag
hbv
hcv
vlp
detect
specif
antibodi
hbv
concentr
centrifug
purifi
heparin
column
gave
similar
result
solubl
lysat
elisa
untransfect
raji
cell
raji
cell
modc
incub
without
hbsag
h
bind
measur
flow
cytometri
intracellular
stain
antibodi
acri
antibodi
gmbh
uptak
compar
bind
mw
molecular
probe
invitrogen
carlsbad
ca
usa
specif
bind
determin
min
preincub
mannan
secret
hbsag
subvir
particl
outnumb
hbv
virion
least
patient
serum
cultur
supernat
cell
enrich
hbv
virion
cultur
supernant
cell
fraction
heparin
column
differ
elut
fraction
assess
hbv
l
elisa
input
fraction
contain
mainli
protein
repres
rel
high
level
secret
spheric
subvir
particl
fig
elut
fraction
howev
highli
enrich
l
protein
confirm
increas
level
hbv
virion
fraction
quantif
input
fraction
elut
fraction
confirm
almost
enrich
hbv
virion
fraction
hbv
particl
per
ml
fig
interact
recombin
hbsag
hbv
determin
bind
elisa
coat
hbsag
hbv
hcv
vlp
medium
control
incub
solubl
recombin
detect
signal
medium
control
never
background
strikingli
interact
hbsag
whole
viru
particl
wherea
interact
hcv
particl
consist
purifi
yeast
recombin
hcv
envelop
protein
fig
specif
bind
determin
block
either
mannan
yeast
cell
deriv
polycarbohydr
competit
bind
carbohydr
bind
site
lectin
calcium
chelat
egta
agent
inde
reduc
bind
hcv
background
level
coat
control
demonstr
approxim
equal
amount
hbsag
hbv
hcv
vlp
coat
base
oligosaccharid
specif
sever
plant
lectin
use
glycan
analysi
hbsag
heparin
purifi
hbv
fig
strong
bind
con
gna
wga
pna
rcaii
lta
demonstr
presenc
high
andor
complex
mannos
galactos
fucos
contain
carbohydr
structur
hbsag
hbv
interact
high
mannos
fucos
contain
oligosaccharid
structur
import
note
carbohydr
structur
hcv
vlp
mannan
mainli
consist
mannos
indic
exclus
bind
con
gna
exclud
possibl
lack
interact
hbv
recombin
improp
multimer
bind
hbsag
hbv
nativ
studi
deriv
transfect
raji
cell
describ
flow
cytometr
analysi
raji
transfect
show
high
express
level
fig
bind
elisa
coat
hbsag
hcv
vlp
incub
lysat
mock
transfect
raji
cell
bound
detect
antibodi
deriv
raji
transfect
bind
hbsag
whole
hbv
particl
wherea
hcv
vlp
show
bind
fig
control
incub
specif
antibodi
indic
equal
amount
coat
background
bind
observ
either
hbsag
hcv
vlp
use
lysat
untransfect
raji
cell
data
shown
addit
elisa
hbsag
interact
cellular
also
determin
highli
express
modc
fig
therefor
modc
incub
hbsag
bind
measur
flow
cytometri
neither
raji
cell
modc
interact
hbsag
h
incub
fig
data
shown
contrast
raji
cell
modc
effici
internalis
ligand
manner
fig
mock
transfect
raji
cell
remain
neg
data
shown
figur
summar
result
two
independ
bind
assay
similar
manner
interact
cellular
hbsag
hbv
determin
use
raji
cell
flow
cytometr
analysi
show
express
level
equal
express
fig
solubl
interact
neither
hbv
hbsag
elisa
wherea
interact
hcv
vlp
fig
medium
control
alway
background
level
moreov
cellular
express
raji
transfect
bind
hbsag
bound
manner
fig
thu
neither
hbsag
hbv
interact
wherea
lectin
interact
hcv
virus
data
suggest
glycosyl
hbv
distinct
virus
evalu
whether
inde
nativ
hbv
glycosyl
meet
requir
interact
glycan
modifi
hbv
gener
treat
cell
inhibitor
kifunensin
kifunensin
caus
accumul
oligosaccharid
glycoprotein
inhibit
mannos
trim
endoplasm
reticulum
carbohydr
analysi
glycan
modifi
hbv
inde
demonstr
increas
amount
mannos
structur
compar
nativ
hbv
shown
increas
bind
plant
lectin
con
gna
bind
lectin
wga
unchang
fig
control
incub
specif
antibodi
show
similar
amount
nativ
highli
glycosyl
hbv
coat
fig
interact
highli
mannosyl
hbv
studi
elisa
fig
strikingli
hbv
bind
observ
kifunensin
treatment
viru
produc
cell
bind
could
inhibit
mannan
egta
protein
structur
hbv
therefor
compat
bind
nativ
glycosyl
exclus
determin
interact
observ
also
exclud
possibl
lack
interact
observ
due
low
sensit
assay
use
studi
supernat
untreat
cell
show
bind
minor
background
bind
observ
supernat
cell
due
accumul
larg
amount
highli
mannosyl
protein
medium
treatment
data
indic
mannos
trim
oligosaccharid
structur
present
hbv
prevent
interact
one
key
question
hbv
biolog
focus
attach
entri
mechan
use
hbv
infect
hepatocyt
main
target
cell
sever
put
bind
receptor
propos
none
confirm
high
affin
receptor
hbv
relat
issu
hbv
entri
way
hbv
reach
hepatocyt
direct
contact
hbv
circul
hepatocyt
possibl
fenestr
lsec
cell
type
involv
hbv
dissemin
similar
hiv
transport
dendrit
cell
cell
hcv
captur
lsec
promot
infect
hepatocyt
sinc
hbsag
glycoprotein
involv
lectin
receptor
viral
recognit
seem
plausibl
lectin
dendrit
homologu
capabl
recogn
broad
rang
glycosyl
pathogen
includ
virus
bacteria
protozoa
fact
hbv
found
attach
dendrit
cell
lsec
lead
like
candid
receptor
present
studi
conclus
show
lack
interact
purifi
hbv
nativ
glycosyl
moreov
recombin
hbsag
recogn
neither
glycan
analysi
hbv
hbsag
demonstr
lack
bind
due
aberr
glycosyl
virion
glycoprotein
use
studi
sinc
observ
glycosyl
pattern
consist
previous
report
carbohydr
structur
hbv
notabl
mannos
seem
present
similar
amount
hbv
hbsag
glycan
structur
virion
enrich
galactos
fucos
differ
observ
glycosyl
pattern
might
result
present
domain
shown
interact
high
glycan
variou
virus
hcv
hiv
ebola
even
though
data
demonstr
virus
exploit
benefit
major
captur
viru
degrad
rout
antigen
present
pathway
therebi
allow
induct
immun
respons
although
hbv
glycoprotein
involv
viral
recognit
known
bind
mannos
bind
lectin
asialoglycoprotein
receptor
shown
trim
oligosaccharid
structur
prevent
recognit
hbv
thu
recogn
soon
one
enzym
format
complex
glycan
inhibit
highli
mannosyl
virion
gener
previou
report
shown
import
hbv
glycosyl
viral
secret
inde
observ
decreas
secret
highli
mannosyl
vs
nativ
hbv
similar
cultur
condit
rule
patient
sera
contain
subpopul
highli
glycosyl
viremia
would
allow
interact
preliminari
data
hbv
deriv
sever
patient
sera
high
viral
load
show
bind
data
shown
therebi
indic
may
involv
recognit
hbv
vivo
either
basi
find
tempt
specul
hbv
exploit
mannos
trim
way
escap
recognit
therebi
subvert
possibl
immun
activ
respons
studi
need
address
issu
author
noth
disclos
